Lanean...
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy
BACKGROUND AND OBJECTIVES: Different rituximab protocols are used to treat membranous nephropathy. We compared two rituximab protocols in patients with membranous nephropathy. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Twenty-eight participants from the NICE cohort received two infusions of...
Gorde:
| Argitaratua izan da: | Clin J Am Soc Nephrol |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society of Nephrology
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6682825/ https://ncbi.nlm.nih.gov/pubmed/31340979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.11791018 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|